Find Novel Oncology Drugs in Clinical Development in JAPAN

Lead Product(s): Undisclosed

Therapeutic Area: Oncology

Highest Development Status: Undisclosed Product Type: Small molecule

Partner/Sponsor/Collaborator: Merck

Deal Size: $2,550.0 million Upfront Cash: $50.0 million

Deal Type: Collaboration January 06, 2020

Details:

Under the terms of the agreement, Merck, Taiho and Astex will combine preclinical candidates and their data with knowledge and expertise from their respective research programs.